Akari Therapeutics (AKTX) Free Cash Flow (2014 - 2026)

Akari Therapeutics (AKTX) reported Free Cash Flow of -$2.5 million for Q1 2026, down 15.72% on a YoY basis from -$3.0 million in Q1 2025, and up 18.18% sequentially from -$3.0 million in Q4 2025.

Akari Therapeutics (AKTX) Free Cash Flow (2014 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has 9 years of Free Cash Flow data on file, last reported at -$2.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Free Cash Flow fell 15.72% year-over-year to -$2.5 million; the trailing twelve-month figure through Mar 2026 stood at -$10.9 million (down 2.33% YoY), and the FY2025 full-year result was -$10.6 million, up 15.81% from the prior year.
  • Free Cash Flow grew to -$2.5 million in Q1 2026, from -$3.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.5 million in Q3 2024 to a low of -$4.9 million in Q2 2024.
  • A 4-year average of -$3.2 million and a median of -$3.0 million in 2025 frame the typical range for Free Cash Flow.
  • Across the five-year window, Free Cash Flow jumped 51.83% in 2024 and plunged 43.17% in 2025, its largest moves.
  • Tracing AKTX's Free Cash Flow over 4 years: stood at -$4.4 million in 2023, then jumped by 51.83% to -$2.1 million in 2024, then sank by 43.17% to -$3.0 million in 2025, then climbed by 18.18% to -$2.5 million in 2026.
  • Business Quant data shows AKTX's Free Cash Flow at -$2.5 million in Q1 2026, -$3.0 million in Q4 2025, and -$2.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -19.58 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.49 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 158.09 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -354.95 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 48.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.49 Mn
Mar 31, 2026 -2.49 Mn
Dec 31, 2025 -3.04 Mn
Dec 31, 2025 -3.04 Mn
Sep 30, 2025 -2.12 Mn
Sep 30, 2025 -2.12 Mn
Jun 30, 2025 -3.26 Mn
Jun 30, 2025 -3.26 Mn
Mar 31, 2025 -2.15 Mn
Mar 31, 2025 -2.15 Mn
Dec 31, 2024 -2.12 Mn
Dec 31, 2024 -2.12 Mn
Sep 30, 2024 -1.49 Mn
Sep 30, 2024 -1.49 Mn
Jun 30, 2024 -4.89 Mn
Jun 30, 2024 -4.89 Mn
Mar 31, 2024 -4.04 Mn
Mar 31, 2024 -4.04 Mn
Dec 31, 2023 -4.41 Mn
Dec 31, 2023 -4.41 Mn